iGMDRD21
Canonical SMILES: C1=C(C(=O)NC(=O)N1)F
InChI: InChI=1S/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9)
InChI Key: GHASVSINZRGABV-UHFFFAOYSA-N
Drug Class:
AntimetabolitesAntimetabolites, AntineoplasticAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsBCRP/ABCG2 SubstratesCardiotoxic antineoplastic agentsCytochrome P-450 CYP1A2 SubstratesCytochrome P-450 CYP2C9 InhibitorsCytochrome P-450 CYP2C9 Inhibitors (strong)Cytochrome P-450 Enzyme InhibitorsFluoropyrimidinesHeterocyclic CompoundsHeterocyclic Compounds, 1-RingImmunologic FactorsImmunosuppressive AgentsMisc. Skin and Mucous Membrane AgentsMyelosuppressive AgentsNoxaeNucleoside Metabolic InhibitorPyrimidine AnaloguesPyrimidinesPyrimidinonesToxic ActionsUracilDrug Pathways:
Pyrimidine metabolismOne carbon pool by folateDrug metabolism - other enzymes Bile secretionDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Fluorouracil
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |